You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | 15.7% | 14.4% |
| ROCE | 49.2% |
| Latest | Forecast | |
|---|---|---|
| P/E | 44.6 | 35.7 |
| PEG | 1.5 | 2.5 |
| Price / Revenue | 6.5 | 4.4 |
| Price / Book value | 10.6 |
| Latest | Forecast | |
|---|---|---|
| Revenue | 26.6% | 0.0% |
| PBT | 153.3% | n/a |
| EPS | 29.6% | 0.0% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 39.23 | -0.22 | 6.80p | 22.4 | -0.8 | -28% | n/a | 0.0% |
| 2017-12-31 | 47.62 | -4.45 | 4.20p | 43.7 | -1.1 | -38% | n/a | 0.0% |
| 2018-12-31 | 54.11 | -10.77 | -20.00p | -7.9 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 68.25 | 4.99 | 19.90p | 19.7 | 0.0 | n/a | n/a | 0.0% |
| 2020-12-31 | 86.39 | 12.63 | 25.80p | 40.9 | 1.4 | 30% | n/a | 0.0% |
| Tuesday broker round-up Sharecast News | 23 Mar |
|---|---|
| Pharmacovigilance drives growth at Ergomed Sharecast News | 23 Mar |
| Ergomed earnings to beat expectations for 2020 Sharecast News | 26 Jan |
| Total Voting Rights | 01-Apr-21 07:00 |
|---|---|
| Audited Full Year Results | 23-Mar-21 07:01 |
| Total Voting Rights | 01-Mar-21 07:01 |
| Holding(s) in Company | 25-Feb-21 08:43 |
| Notice of Preliminary Results | 10-Feb-21 07:01 |